ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
•26 Sep 2023 09:25•Broker

Recommendation: Hold Cash If Index Falls Below the Support

Asian stock markets exhibited mixed performances, accompanied by a depreciation of the baht and an uptick in Thai 10-year bond yields. The index...

Logo
85 Views
Share
bearish•Macroeconomics
•25 Sep 2023 15:45•Broker

KTX Expects the MPC to End the Interest Rate Uptrend at 2.25%

KTX identified potential signals indicating the conclusion of the interest rate uptrend. The MPC may revise down the 2023E Thai GDP forecast from...

Logo
88 Views
Share
•18 Aug 2026 15:05•Broker

KTX TACTICAL PICKS - August 18, 2026 (Eng.)

We recommend cutting losses on TCAP (a holding-period return of -5.2%) and selling COM7 (+0.7%) after both stocks fell out of our ranking...

Logo
92 Views
Share
•15 Jun 2023 15:35•Broker

Fund Managers Drop Stocks as Economic Worries Stay High

FMS investors reduced the weighting of all risk asset classes but increased the weighting of alternative investments and real estate. Investors...

Logo
87 Views
Share
bullish•Macroeconomics
•12 Jun 2023 17:53•Broker

Expect Positive Surprises From the US

The US CPI in May 2023 may have benefited from the high base YoY, and it could have weakened on a MoM basis due to the 11.3% MoM decline in global...

Logo
82 Views
Share
x